Patents by Inventor Katherine D. Crothall

Katherine D. Crothall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8932250
    Abstract: A disease management system, methods, and devices are shown and described. In one embodiment, the system includes an infusion pump and a remote controller with the ability to be paired to each other. A method to verify a wireless connection between an infusion pump and a remote controller is shown and described herein. In a further embodiment, a method to verify a wireless connection between an infusion pump and a remote controller is provided. In addition, a method of operating a diabetes management system is provided in which the system includes an infusion pump and at least a remote controller.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: January 13, 2015
    Assignee: Animas Corporation
    Inventors: Barbara A. Montgomery, Krzysztof Z. Brukalo, Manfred Ebner, Steven Getz, Carl Brewer, Ulrich Kraft, Mark DeStefano, Sieghard Hasenzahl, Katherine D. Crothall, David Hohl
  • Publication number: 20080312584
    Abstract: A disease management system, methods, and devices are shown and described. In one embodiment, the system includes an infusion pump and a remote controller with the ability to be paired to each other. A method to verify a wireless connection between an infusion pump and a remote controller is shown and described herein. In a further embodiment, a method to verify a wireless connection between an infusion pump and a remote controller is provided. In addition, a method of operating a diabetes management system is provided in which the system includes an infusion pump and at least a remote controller.
    Type: Application
    Filed: June 15, 2007
    Publication date: December 18, 2008
    Applicant: Animas Corporation
    Inventors: Barbara A. Montgomery, Krzysztof Z. Brukalo, Manfred Ebner, Steven Getz, Carl Brewer, Ulrich Kraft, Mark DeStefano, Sieghard Hasenzahl, Katherine D. Crothall, David Hohl
  • Patent number: 7179226
    Abstract: A diabetes management system and method used to manage the blood glucose level of a diabetes patient. The system includes at least one portable electronic device and a database system. The portable electronic device allows the patient to input different types of data into the processor to calculate insulin and carbohydrate intake recommendations for the patient. A time/date stamp is individually generated and stored for each type of data inputted by the patient. The diabetes management system also includes a database system which stores (i) activity data associated with the physical activity of the patient, (ii) blood glucose data associated with the blood glucose level of the patient, (iii) meal intake data associated with the food intake of the patient, and (iv) insulin intake data associated with the insulin intake of the patient.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: February 20, 2007
    Assignee: Animas Corporation
    Inventors: Katherine D. Crothall, Bogdan Butoi-Teodorescu, Peter Laakmann
  • Publication number: 20030032867
    Abstract: A diabetes management system and method used to manage the blood glucose level of a diabetes patient. The system includes at least one portable electronic device and a database system. The portable electronic device allows the patient to input different types of data into the processor to calculate insulin and carbohydrate intake recommendations for the patient. A time/date stamp is individually generated and stored for each type of data inputted by the patient. The diabetes management system also includes a database system which stores (i) activity data associated with the physical activity of the patient, (ii) blood glucose data associated with the blood glucose level of the patient, (iii) meal intake data associated with the food intake of the patient, and (iv) insulin intake data associated with the insulin intake of the patient.
    Type: Application
    Filed: June 19, 2002
    Publication date: February 13, 2003
    Applicant: Animas Corporation.
    Inventors: Katherine D. Crothall, Bogdan Butoi-Teodorescu, Peter Laakmann
  • Patent number: 6122536
    Abstract: This invention is an implantable sensor and system capable of measuring, controlling, monitoring and reporting blood constituent levels. The implantable sensor for sensing in vivo the level of at least one blood constituent in mammalian vascular tissue having at least one source of radiation from infrared through visible light, arranged to direct the radiation at the tissue where it is affected by interaction with the tissue, and at least one detector. The invention also encompasses a device for measuring and controlling the level of a blood constituent, such as glucose or oxygen, and includes an implantable infrared source module for generating an output signal representative of the sensed infrared radiation. The system includes a processor module responsive to the output signal which performs spectral analysis of the output signal and generates a control signal. The system further includes other devices for dispensing doses of medications or controlling organ function in response to the control signal.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: September 19, 2000
    Assignee: Animas Corporation
    Inventors: Xiaoguong Sun, Jeffrey I. Joseph, Katherine D. Crothall
  • Patent number: 6049727
    Abstract: An in vivo implantable sensor obtains spectra of body fluid constituents and processes the spectra to determine the concentration of a constituent of the body fluid. The sensor includes an optical source and detector. The source emits light at a `plurality of different, discrete wavelengths, including at least one wavelength in the infrared region. The light interacts with the body fluid and is received at the detector. The light at the plurality of different wavelengths has a substantially collinear optical path through the fluid with respect to each other. When measuring fluid constituents in a blood vessel, such as blood glucose, the light at the plurality of different wavelengths is emitted in a substantially single period of time. The spectra is corrected for artifacts introduced from extraneous tissue in the optical path between the source and the detector. The sensor is fully implanted and is set in place to allow plural measurements to be taken at different time periods from a single in vivo position.
    Type: Grant
    Filed: April 3, 1998
    Date of Patent: April 11, 2000
    Assignee: Animas Corporation
    Inventor: Katherine D. Crothall
  • Patent number: 5596593
    Abstract: A gas laser having a housing including a discharge region that contains a lasing gas medium, a pair of DC electrodes having primary surfaces facing toward the discharge region, the primary surfaces being arranged in substantially parallel planes, and a pair of RF electrodes having secondary surfaces facing toward the discharge region, the secondary surfaces being in substantially parallel planes with the secondary surfaces being arranged substantially orthogonal to the primary surfaces. The gas laser also has an RF power source connected between said pair of RF electrodes and selectively generating an RF discharge in the discharge region, and a DC power source connected between said pair of DC electrodes and selectively generating a DC discharge in the discharge region.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: January 21, 1997
    Assignee: Luxar Corporation
    Inventors: Katherine D. Crothall, Edward S. Schieferstein, Steven E. Wojcik